A follow-up programme for patients using Symbicort SMART in normal clinical practice

Study identifier:D5890C00018

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A follow-up programme for patients using Symbicort SMART in normal clinical practice

Medical condition

Bronchial Asthma

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

5137

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Jul 2007
Primary Completion Date: 01 Apr 2010
Study Completion Date: 01 Apr 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria